original ) (raw )Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
Eric Achtyes
BMC psychiatry, 2018
View PDFchevron_right
Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study
Michael Bloch
Journal of Child and Adolescent Psychopharmacology, 2018
View PDFchevron_right
Impact of Switching or Initiating Antipsychotic Treatment on Body Weight During a 6-Month Follow-Up in a Cohort of Patients With Schizophrenia
Denis Leguay
Journal of Clinical Psychopharmacology, 2012
View PDFchevron_right
Patients’ Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment
LESLIE CITROME
Psychiatric Services, 2015
View PDFchevron_right
45 – Non-pharmacological management of weight gain: A national, multicentric study for schizophrenia and severe mental disorders patients
Larissa Campagna Martini
Schizophrenia Research, 2008
View PDFchevron_right
Weight gain from novel antipsychotic drugs: need for action
R. Goisman
General Hospital Psychiatry, 2000
View PDFchevron_right
Risk of adverse events associated with antipsychotic treatment — Results from the Canadian national outcomes measurement study in schizophrenia
R. Balshaw
European Neuropsychopharmacology, 2001
View PDFchevron_right
The experience of weight gain as a result of taking second-generation antipsychotic medications: the mental health consumer perspective
kim usher
Journal of Psychiatric and Mental Health Nursing, 2012
View PDFchevron_right
Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
Takefumi Suzuki
Schizophrenia Bulletin, 2014
View PDFchevron_right
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
Bruce J Kinon
BMC psychiatry, 2005
View PDFchevron_right
Pharmacological Add-On Treatments in Managing Antipsychotic-Induced Weight Gain
Codrina Moraru
The European Conference of Psychiatry and Mental Health "Galatia"
View PDFchevron_right
Subjective side effects of antipsychotics and medication adherence in people with schizophrenia
Terence McCann
Journal of Advanced Nursing, 2009
View PDFchevron_right
The association between weight change and symptom reduction in the CATIE schizophrenia trial
jeffrey lieberman
Schizophrenia Research, 2011
View PDFchevron_right
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
Ilona Gorbovskaya
Frontiers in neuroscience, 2017
View PDFchevron_right
Atypical Antipsychotic Induced Weight Gain in Schizophrenic Patients
tetie herlina
Indonesian Journal of Clinical Pharmacy, 2021
View PDFchevron_right
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements
Jason Noel
2010
View PDFchevron_right
The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
Mohammad Nikseresht
Schizophrenia Research, 2013
View PDFchevron_right
The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial
Franca Centorrino
Schizophrenia Research, 2019
View PDFchevron_right
Psychiatrist and Psychiatric Pharmacists Beliefs and Preferences for Atypical Antipsychotic Treatments in Patients With Schizophrenia and Bipolar Disorders
Dolly Sharma
Journal of Pharmacy Practice, 2019
View PDFchevron_right
Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia
Peter Weiden
The Journal of clinical psychiatry, 2007
View PDFchevron_right
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
Inge Winter
BMC Psychiatry
View PDFchevron_right
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
Gail Robinson
Therapeutic Advances in Psychopharmacology, 2021
View PDFchevron_right
Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
katarina kelin
Neuropsychiatric Disease and Treatment, 2012
View PDFchevron_right
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis
CLAUDIA ANDREA TORRES LOBOS
Schizophrenia research, 2010
View PDFchevron_right
Association between antipsychotic medication and clinically relevant weight change: meta-analysis
Bea Campforts
View PDFchevron_right
The Schizophrenia PORT Pharmacological Treatment Recommendations: Conformance and Implications for Symptoms and Functional Outcome
Julie Kreyenbuhl
Schizophrenia Bulletin, 2002
View PDFchevron_right
Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis
Julia Vakhrusheva
Neuropsychopharmacology, 2010
View PDFchevron_right
Weight gain and antipsychotics. Data from EUFEST study
Valentin Matei , Traian Purnichi
View PDFchevron_right
Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder
영준 신
The Journal of Clinical Psychiatry, 2006
View PDFchevron_right
Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: One-year analysis
Martin Strassnig , J. Miewald
Schizophrenia Research, 2007
View PDFchevron_right
Antipsychotic Medications and Weight Gain: Etiologies, Predictors and Adverse Clinical Consequences
Saud Alsanad
International Neuropsychiatric Disease Journal, 2018
View PDFchevron_right
Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study
Gabriela Hernandez
Schizophrenia Research, 2003
View PDFchevron_right
Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis
Sahoo Saddichha
Journal of Clinical Psychopharmacology, 2008
View PDFchevron_right